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Background: Measurement of inulin clearance is considered to be the gold standard 
for determining kidney function in children, but this method is time consuming and 
expensive. The glomerular filtration rate (GFR) is on the other hand easier to calculate 
by using various creatinine- and/or cystatin C (Cys C)-based formulas. However, for the 
determination of serum creatinine (Scr) and Cys C, different and non-interchangeable 
analytical methods exist. Given the fact that different analytical methods for the deter-
mination of creatinine and Cys C were used in order to validate existing GFR formulas, 
clinicians should be aware of the type used in their local laboratory. In this study, we 
compared GFR results calculated on the basis of different GFR formulas and either used 
Scr and Cys C values as determined by the analytical method originally employed for 
validation or values obtained by an alternative analytical method to evaluate any possible 
effects on the performance.
Methods: Cys C values determined by means of an immunoturbidimetric assay were 
used for calculating the GFR using equations in which this analytical method had  originally 
been used for validation. Additionally, these same values were then used in other GFR 
formulas that had originally been validated using a nephelometric immunoassay for 
determining Cys C. The effect of using either the compatible or the possibly incompatible 
analytical method for determining Cys C in the calculation of GFR was assessed in 
comparison with the GFR measured by creatinine clearance (CrCl).
results: Unexpectedly, using GFR equations that employed Cys C values derived 
from a possibly incompatible analytical method did not result in a significant difference 
concerning the classification of patients as having normal or reduced GFR compared to 
the classification obtained on the basis of CrCl. Sensitivity and specificity were adequate. 
On the other hand, formulas using Cys C values derived from a compatible analytical 
method partly showed insufficient performance when compared to CrCl.
conclusion: Although clinicians should be aware of applying a GFR formula that is 
compatible with the locally used analytical method for determining Cys C and creatinine, 
other factors might be more crucial for the calculation of correct GFR values.
Keywords: cystatin c, creatinine, glomerular filtration rate, creatinine clearance, glomerular filtration rate formulas
TaBle 1 | gFr formulas used in the study (4, 7–12).
creatinine 
assay
cys c assay equation
creatinine- and cys c-based
Multivariable 
Schwartz
IDMS Turbidimetry GFR = 39.1 [height (m)/
Scr (mg/dl)]0.516 × [1.8/
cystatin C (mg/l)]0.294 × [30/
BUN (mg/dl)]0.169 × 1.099 if 
male × [height (m)/1.4]0.188
creatinine-based
Creatinine-
based 
Schwartz
IDMS – GFR = K × height (cm)/Scr  
(mg/dl); K: 0.413
cys c-based
Grubb – Turbidimetry GFR = 84.69 × [cystatin C 
(mg/l)]−1.680 × 1.384if <14 years
Le Bricon – Nephelometry GFR = 78/cystatin C (mg/l) + 4
Rule – Nephelometry GFR = 76.6 × [cystatin C 
(mg/l)]−1.16
Filler – Nephelometry Log 
(GFR) = 1.962 + [1.123 × log 
(1/cystatin C (mg/l))]
GFR, glomerular filtration rate; Cys C, cystatin C; IDMS, isotope dilution mass 
spectrometry; Scr, serum creatinine; BUN, blood urea nitrogen.
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inTrODUcTiOn
Estimation of the glomerular filtration rate (GFR) is essential 
for the diagnosis and follow-up of patients with suspected or 
confirmed kidney disease. Several methods for predicting GFR 
are available (1). Despite the fact that the inulin clearance test is 
the gold standard for assessing GFR, it is labor intensive, invasive, 
and not available in all centers (2). In contrast, methods based 
on endogenous markers such as serum creatinine (Scr) are con-
venient and easy to perform (3). Scr concentrations are highly 
variable depending on muscle mass, activity, nutritional state, 
and diet and have to be adjusted for gender, body height, and 
body composition to reflect renal function in pediatric patients 
accurately. Unlike Scr, serum cystatin C (Cys C) is produced at a 
constant rate by all nucleated body cells and is independent of age 
and gender (4–6). Therefore, Cys C might be of special benefit as 
a marker of GFR in the pediatric population.
Presently, a large array of creatinine- or Cys C-based and com-
bined formulas is available for the calculation of GFR in children. 
Clinicians may be confused as to which formula would best be 
used in their setting. Apart from such aspects as the feasibility of 
the formula and the possibility to use it at the bedside, clinicians 
should be aware of the various different analytical methods used 
for determining Scr and Cys C as the type of analytical method 
employed could influence the performance of the formulas. Scr 
can be measured by the Jaffe method or by means of enzymatic 
testing; Cys C, on the other hand, is determined by means of 
nephelometric or turbidimetric immunoassays. Methods of 
determining Scr can be used interchangeably with the different 
GFR formulas if they are isotope dilution mass spectrometry 
(IDMS) traceable. For Cys C, however, there is no method of 
adjustment available for the various alternative laboratory tests 
in routine use so far. Consequently, the choice of a specific GFR 
formula that uses a Cys C value derived from a possibly incom-
patible analytical method could lead to incorrect results and to 
a misclassification of renal function. This study is assessing the 
performance of different GFR formulas compared to creatinine 
clearance (CrCl) and evaluates the impact of the type of analytical 
method used for determining Cys C and Scr on the calculation 
of the GFR.
MaTerials anD MeThODs
Patients
One hundred forty-one children and adolescents treated between 
2004 and 2009 at the Department of Pediatric Nephrology of the 
Children’s University Hospital, Munich, Germany, were enrolled 
in this study. The study population consisted of pediatric patients 
between 2 and 18  years of age with renal disease, metabolic 
diseases, and malignancies. All pediatric in- and outpatients 
who were presented to the division of pediatric nephrology for 
determining of renal function were analyzed. The patients were 
clinically stable. Patients below the age of 2 were not included, as 
the children had to have arbitrary voiding for determining the 
CrCl by 24-h urine collection. Children with gross proteinuria 
and those on steroids were excluded, as these conditions influ-
ence CrCl. Only one set of simultaneous measurements of CrCl, 
Scr, and Cys C from each patient was used in the analysis. All 
parameters analyzed were measured on clinical grounds. The 
data were collected retrospectively and irreversibly anonymized. 
Therefore, ethical clearance and an informed consent were not 
required.
Measurements and analytical Methods
Patient height and weight were measured in the hospital 
using standardized scales. Scr (milligrams per deciliter) was 
determined by an IDMS-traceable method using a Hitachi 911 
autoanalyzer. Cys C (mg/l) was measured in serum samples 
using an immunoturbidimetric assay with a 501c analyzer 
of the Cobas 6000 series (Roche Diagnostics). The following 
equations for the calculation of a GFR estimate (eGFR, ml/
min/1.73 m2) based on Scr, Cys C, or both were tested (Table 1): 
multivariable Schwartz, creatinine-based Schwartz, Le Bricon, 
Rule, Filler, and Grubb. While the multiple  parameter Schwartz 
and the Grubb equations were developed using an immunotur-
bidimetric assay comparable to the assay used in our laboratory, 
the equations by Le Bricon, Rule, and Filler were established 
using a nephelometric immunoassay for the measurement of 
Cys C (4, 7–12).
Creatinine clearance (CrCl) was calculated from Scr and 
urinary creatinine excretion over 24 h according to the following 
formula: urine volume (ml) × urine creatinine (mg/dL) × 1.73/
serum creatinine (mg/dL) × body surface area (m2) × collection 
time (min). Patients and their parents were instructed on the col-
lection of 24 h urine by dedicated nurses according to standard 
procedures. Urine was collected as a one-time collection at the 
time of an outpatient visit or in the course of an inpatient visit. 
Serum samples were collected on the same day the urine collec-
tion was performed.
TaBle 2 | Overview of the demographic data and cKD stages of the 
patient population (13).
Age (median, range) 10.1 (2.4–18.6)
Female (N, %) 63 (44.7)
Male (N, %) 78 (55.3)
Height in cm (median, range) 136.1 (86.4–191.5)
Weight in kg (median, range) 32.2 (12.4–90.5)
BMI (median, range) 17.3 (12.4–32.0)
CKD stages (N, %)
1 89 (63.1)
2 26 (18.4)
3 21 (14.9)
4 4 (2.8)
5 1 (0.7)
TaBle 3 | Mean glomerular filtration rates estimated by creatinine- and 
cystatin c (cys c)-based, creatinine-based, and cys c-based equations.
equation Value
creatinine- and cys c-based
Multivariable Schwartz 90 ± 36 (13–186)
creatinine-based
Creatinine-based Schwartz 100 ± 48 (4–240)
Creatinine clearance 116 ± 60 (7–369)
cys c-based
Grubb 161 ± 94 (7–466)
Le Bricon 98 ± 35 (21–181)
Rule 102 ± 40 (13–199)
Filler 114 ± 46 (17–230)
Values are mean ± SD (range), and all units are ml/min/1.73 m2.
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statistical analysis
The SPSS software (Statistical Package for the Social Sciences, 
version 20.0, SPSS Inc., Chicago, IL, USA) was used for statistical 
analysis. Data are presented as mean ± SD (GFR) or median and 
range [age, height, Scr, Cys C, and blood urea nitrogen (BUN)]. 
Normal distribution was assessed using the Kolmogorov–
Smirnov test. Pearson’s correlation was performed to test for 
linear correlations between continuous variables. The bias of each 
eGFR formula compared to CrCl was calculated as the difference 
between CrCl and the results of the respective eGFR equation. 
Accuracy was measured as the interquartile range (IQR) of the 
difference between CrCl and the respective eGFRs and as the 
proportion of eGFR values within 10, 30, and 50% of measured 
CrCl. Sensitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV) for the detection of impaired 
renal function (i.e., CrCl < 90 ml/min/1.73 m2) were calculated 
for each formula with the CrCl serving as gold standard. Bland–
Altman plots were created to visualize the performance of the 
different eGFR formulas. Both receiver operating characteristic 
(ROC) curves and contingency tables analyzed by McNemar’s test 
were used to evaluate the correct classification of patient eGFR 
values into the normal (≥90  ml/min/1.73  m2) or pathological 
(<90 ml/min/1.73 m2) range with CrCl serving as gold standard. 
The level of statistical significance was set at a p < 0.05.
resUlTs
Patient age ranged between 2 and 18 years (median 10.1 years). 
Sixty-three children (44.7%) were female. Median height was 
136.1  cm (range 86.4–191.5  cm) (Table  2). Median Scr was 
0.60  mg/dl (range 0.2–11.0  mg/dl), median Cys C 0.78  mg/l 
(range 0.4–4.6 mg/l), and median BUN 15 mg/dl (range 2–86 mg/
dl). Mean CrCl was 116 ±  60  ml/min/1.73  m2, 52/141 (37%) 
patients had a GFR <90 ml/min/1.73 m2 as measured by the CrCl 
(Table 2). The results of the different eGFR equations are sum-
marized in Table 3. All eGFR formulas were highly significantly 
correlated to CrCl (data not shown).
Data on bias and precision are presented in Table 4. The mul-
tivariable Schwartz, creatinine-based Schwartz, the Le Bricon, 
and the Rule formulas underestimated the GFR, whereas the 
other formulas overestimated it. The Filler formula showed only 
a very small median bias (Table 4). IQRs were large especially 
for the Grubb formula. Therefore, the proportion of values 
between ±10, 30, and 50% of CrCl was low for this formula. In 
the Bland–Altman analysis, the limits of agreement for all for-
mulas were wide, especially in the range of GFR values ≥90 ml/
min/1.73 m2 but could be substantially reduced if only patients 
with a GFR of <90  ml/min/1.73  m2 were analyzed (data not 
shown). The Le Bricon, Rule, Filler, and multivariable Schwartz 
formulas showed a tendency to underestimate the GFR the 
Grubb formula a tendency to overestimate it with higher values 
in the Bland–Altman analysis. There was no trend in the case 
of the creatinine-based Schwartz formula (data shown for the 
creatinine-based Schwartz formula, Figure 1, and the Le Bricon 
formula, Figure 2).
Using the CrCl as gold standard sensitivity, specific-
ity, PPV, and NPV were calculated for the different eGFR 
formulas (Table 4). The multivariable Schwartz formula and the 
 creatinine-based Schwartz formula showed good sensitivity and 
specificity compared to CrCl, but the PPV was slightly below 
70% in both formulas. The Grubb formula, which is based on 
the turbidimetric immunoassay for Cys C, had lower  sensitivity 
than the immunonephelometric Filler equation while both 
had comparable specificity (Table  4). The different eGFR 
equations were compared with the CrCl in order to ascertain 
whether they classified patients correctly in the group with 
normal GFR (≥90 ml/min/1.73 m2) or reduced GFR (<90 ml/
min/1.73  m2). The multivariable Schwartz formula classified 
77%, the creatinine-based Schwartz formula 79%, the Grubb 
formula 78%, the Le Bricon formula 81%, the Rule formula 
78%, and the Filler formula 83% of the patients correctly. The 
multivariable Schwartz, the creatinine-based Schwartz, and 
the Le Bricon formulas misclassified 14–17% of patients with 
normal GFR while the Grubb equation incorrectly classified 
15% of patients with reduced GFR as normal (Table 5). ROC 
analysis of the predictive performance of the different formulas 
(Figure 3) showed comparable areas under the curve ranging 
from 0.809 to 0.875 (Table 6).
DiscUssiOn
Correct estimation of GFR is crucial for detection, evaluation, 
and treatment of renal diseases (5). The classical parameter to 
assess renal function is Scr, and GFR is estimated on the basis of 
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FigUre 1 | Bland–altman plot for the creatinine-based schwartz formula versus creatinine clearance.
TaBle 4 | Median bias, precision (iQr), and accuracy (P10, P30, and P50) for the multivariable schwartz, creatinine-based schwartz, grubb, le Bricon, 
rule, and Filler formulas.
Median bias iQr P10 (%) P30 (%) P50 (%) sensitivity (%) specificity (%) PPV (%) nPV (%)
Multivariable Schwartz −19.1 43.1 21 64 94 85 (72–93) 73 (64–82) 65 (52–76) 89 (80–95)
Creatinine-based Schwartz −12.5 30.7 28 67 92 83 (70–92) 76 (66–85) 67 (54–78) 88 (79–95)
Grubb 29.9 93.9 18 41 62 60 (45–73) 89 (80–95) 76 (60–88) 79 (70–87)
Le Bricon −14.2 46.3 18 60 87 79 (65–89) 82 (73–89) 72 (59–83) 87 (78–93)
Rule −16.8 42.8 18 62 87 79 (65–89) 78 (67–86) 67 (54–79) 86 (77–93)
Filler 2.6 40.5 26 60 87 73 (59–84) 89 (80–95) 79 (65–90) 95 (76–92)
IQR, interquartile range; P10, P30, and P50, percentage of eGFR within 10, 30, and 50% of CrCl, respectively. Specificity, sensitivity, positive predictive value (PPV), and negative 
predictive value (NPV) for all eGFRs.
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creatinine-based formulas. Creatinine-based estimation of GFR, 
however, has distinct limitations. Recent reports demonstrate 
that among all available markers Cys C is the best marker of renal 
function and a valid test for diagnosis of renal impairment (3, 5). 
Bacchetta et al., for example, reported a good performance of Cys 
C-based formulas (Le Bricon, Larsson) compared to the inulin 
clearance (14).
In the present study, the creatinine-based Schwartz formula, the 
multivariable Schwartz formula, and the cystatin-C-based Grubb, 
Le Bricon, Rule, and Filler formulas were evaluated in comparison 
to the CrCl in a cohort of pediatric patients with a variety of renal 
and extrarenal diseases requiring GFR measurement.
Several pitfalls have to be considered when calculating the GFR 
by different formulas. Concerning the creatinine-based formulas 
there are two different ways of measuring Scr values, which are the 
Jaffe method and the enzymatic assay. In Germany, the Jaffe method 
is still regarded as standard method for measuring Scr. Although 
this method is cost-effective, it is hampered by interferences of up to 
20% of non-creatinine chromogenes. The problem of interferences 
has been reduced by the enzymatic assays. Additionally, there is 
the issue of varying specificities when Scr is measured in different 
laboratories (15–17). This can lead to an inadequate calculation of 
the GFR when creatinine-based formulas are used. To overcome 
this problem, standardization of Scr measurements can be achieved 
by using a method that is IDMS traceable. Both new Schwartz 
formulas (creatinine-based and multivariable) have been evaluated 
using an IDMS-traceable method. Therefore, the Scr measurement 
at the local hospital has to be IDMS-traceable if these formulas are 
TaBle 5 | glomerular filtration rate (gFr) estimated by multivariable schwartz, creatinine-based schwartz, grubb, le Bricon, rule, and Filler formulas 
compared to the creatinine clearance (crcl).
reduced gFr estimated by crcl normal gFr estimated by crcl pa
normal gFr reduced gFr normal gFr reduced gFr
N % N % N % N %
Multivariable Schwartz 8 6 44 31 65 46 24 17 <0.01
Creatinine-based Schwartz 9 6 43 30 68 48 21 15 0.045
Grubb 21 15 31 22 79 56 10 7 0.072
Le Bricon 11 8 41 29 73 52 16 11 0.441
Rule 11 8 41 29 69 49 20 14 0.151
Filler 14 10 38 27 79 56 10 7 0.541
Reduced estimated GFR defined as <90 ml/min/1.73 m2. Normal estimated GFR defined as ≥90 ml/min/1.73 m2.
aMcNemar’s test.
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FigUre 2 | Bland–altman plot for the le Bricon formula versus creatinine clearance.
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to be used for calculating the GFR. A similar problem arises when 
Cys C-based formulas are used. There are two different ways 
of measuring Cys C: the turbidimetric and the nephelometric 
immunoassays. Unfortunately, however, the results of these two 
assays cannot be used interchangeably. To overcome this prob-
lem, the IFCC Working Group for the Standardization of Cys C 
announced in 2010 the availability of the new certified reference 
material ERM-DA471/IFCC to be used primarily for the calibration 
of immunoassay-based in vitro diagnostic devices concerning the 
measurement of Cys C (18). In future, the two methods for Cys C 
measurement could be used interchangeably if this calibrator mate-
rial is applied. Up to now, it is still necessary to check back with the 
local laboratory to find out which test method was used.
The formulas that were combined with a compatible analytical 
method, especially the multivariable Schwartz and the creatinine-
based Schwartz formula, showed a good performance in our 
cohort. Although both Schwartz formulas classified significantly 
more patients in the group of reduced GFR compared to the CrCl, 
there is a tendency in the CrCl to overestimate the GFR, which 
in turn may be responsible for this effect. The Grubb formula 
showed a lower sensitivity compared to the other formulas, which 
might lead to insufficient detection of patients with a reduced 
GFR. On the other hand, the formulas using a value derived from 
a possibly incompatible analytical method (Le Bricon, Rule, and 
Filler formulas) showed a comparatively good performance com-
pared to the CrCl. There was no significantly different assessment 
TaBle 6 | Overview of the area under the curve for the different 
glomerular filtration rate (gFr) formulas (detection of reduced gFr).
area under the curve
Multivariable Schwartz 0.865*
Creatinine-based Schwartz 0.875*
Grubb 0.809*
Le Bricon 0.821*
Rule 0.821*
Filler 0.821*
*p < 0.001.
1 - Specificity
1,00,80,60,40,20,0
Se
ns
iti
vi
ty
1,0
0,8
0,6
0,4
0,2
0,0
Filler
Rule
Le Bricon
Grubb
Creatinine-based Schwartz
Multivariable Schwartz
FigUre 3 | receiver operating characteristic curves for the different glomerular filtration rate (gFr) formulas (detection of gFr <90 ml/
min/1.73 m2).
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of the GFR and the percentage of concordant classification was 
similar to the other adequately applied formulas.
A drawback of our study design is the use of the CrCl as a gold 
standard. It has to be noted that the CrCl method involves precise 
urine collection for 24 h, which is hard to obtain in young children 
and very time consuming (3). Moreover, due to Scr excretion 
via renal tubular secretion, the measurement of CrCl tends to 
overestimate the true level of GFR (3, 19, 20). This overestimation 
is difficult to quantify because it can be increased by renal diseases 
and reduced by certain drugs (20). Therefore, this method is 
prone to error, and its use as a general standard is limited. In our 
study, preanalytical mistakes of false sampling were excluded to 
the greatest possible extent by a sampling protocol that had to be 
conducted exactly.
As regards the PPV and NPV for detecting a reduced GFR, it 
has to be pointed out that the prevalence of reduced GFR in our 
cohort is much higher than in the general population. As PPV 
and NPV depend on the prevalence, the PPV is expected to be 
higher and the NPV expected to be lower in our study than if the 
formulas were to be applied in the general population. Although 
we did not do a formal sample size calculation, the narrow con-
fidence intervals for sensitivity, specificity, PPV, and NPV show 
that our study was adequately powered to compare descriptively 
the eGFR formulas. As there were two significant results in the 
McNemar’s test, this additionally shows that the sample size used 
7Alberer et al. Comparison of GFR Estimating Formulas in Children
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was sufficiently large to detect relevant differences between the 
CrCl and the eGFR formulas.
In summary, we found no significant impact when using the 
possibly incompatible Cys C-based eGFR equations. Therefore, 
clinicians could use their local Cys C values with the Le Bricon, 
Rule, and Filler eGFR formulas without worrying about an incom-
patible analytical method. As the method of Scr measurement in 
our laboratory was IDMS traceable, any impact that an incom-
patible eGFR equation for Scr might have could not be assessed. 
This might be of less clinical significance as most laboratories will 
have established IDMS-traceable methods for evaluating the Scr. 
Nevertheless, even correctly applied GFR formulas may show 
insufficient performance when judging the GFR in children. We 
conclude from our study that using only the compatible analytical 
method for Cys C when calculating the eGFR is of lesser impor-
tance. The imprecision of the formulas used seems to depend on 
other factors that might be due to the composition of the original 
cohort to generate the algorithm. Therefore, a critical evaluation 
of different GFR formulas in the local setting has to be considered, 
and a combination of several formulas might be useful if a gold 
standard method is not available.
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